FDA.reportPublic FDA data

adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KG

RxCUI
2641672
RxNorm name
adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KG
Display name
adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KG
Full name
adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KG
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761071Hyrimozadalimumab-adaz351(k) InterchangeableRx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1ac7d061-3380-468c-b077-c05f8dfbc829adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KGPSN13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc829{1 (0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe) / 1 (0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe) } PackGPCK13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc829adalimumab-adaz Pediatric Crohn's Starter Kit Patient Weight < 40 KGSY13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017